# EDGAR Filing Document

**Accession Number:** 0001800682
**File Stem:** 0001193125-23-071453
**Filing Date:** 2023-3
**Character Count:** 15475
**Document Hash:** 958f859c1d4d6e436fbe90d21d345b9e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-071453.hdr.sgml**: 20230315

**ACCESSION NUMBER**: 0001193125-23-071453

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 5

**FILED AS OF DATE**: 20230315

**DATE AS OF CHANGE**: 20230315

**EFFECTIVENESS DATE**: 20230315

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cano Health, Inc.
- **CENTRAL INDEX KEY:** 0001800682
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-270576
- **FILM NUMBER:** 23736055

**BUSINESS ADDRESS:**
- **STREET 1:** 9725 NW 117TH AVENUE, SUITE 200
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33178
- **BUSINESS PHONE:** 2034227700

**MAIL ADDRESS:**
- **STREET 1:** 9725 NW 117TH AVENUE, SUITE 200
- **CITY:** MIAMI
- **STATE:** FL
- **ZIP:** 33178

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Jaws Acquisition Corp.
- **DATE OF NAME CHANGE:** 20200121

**As filed with the U.S. Securities and Exchange Commission on March 15, 2023** 

**Registration No. 333-** 

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549** 

------

**FORM S-8** 

**REGISTRATION STATEMENT** 

***UNDER***

***THE SECURITIES ACT OF 1933***

------

## Cano Health, Inc.
**(Exact name of registrant as specified in its charter)** 

------

---

| | |
|:---|:---|
| Delaware | 98-1524224 |
| **(State or other jurisdiction of**<br> **incorporation or organization)** | **(I.R.S. Employer**<br> **Identification Number)** |

---

---

| | |
|:---|:---|
| **9725 NW 117th Avenue** |  |
| **Miami, FL** | **33178** |
| **(Address of principal executive offices)** | **(Zip Code)** |

---

**Cano Health, Inc. 2021 Employee Stock Purchase Plan** 

**(Full titles of the plans)** 

**Dr. Marlow Hernandez** 

**Chief Executive Officer** 

**Cano Health, Inc.** 

**9725 NW 117th Avenue** 

**Miami, Florida 33178** 

**(Name and address of agent for service)** 

**(855) 226-6633** 

**(Telephone number, including area code, of agent for service)** 

***Copies to:***

---

| | |
|:---|:---|
| **Audrey S. Leigh, Esq.**<br> **Goodwin Procter LLP**<br> **The New York Times Building**<br> **620 Eighth Avenue**<br> **New York, NY 10018**<br> **(212) 813-8800** | **David Armstrong, Esq.**<br> **General Counsel**<br> **Cano Health, Inc.**<br> **9725 NW 117th Avenue**<br> **Miami, FL 33178**<br> **(855) 226-6633** |

---

------

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

------

**REGISTRATION OF ADDITIONAL SECURITIES PURSUANT TO GENERAL INSTRUCTIONS E** 

This Registration Statement on Form S-8 (this "Registration Statement") is being filed by Cano Health, Inc. with the Securities and Exchange Commission (the "Commission") to register 2,259,178 additional shares of its Class A common stock, par value $0.0001 per share (the "Common Stock"), reserved for issuance under the Cano Health, Inc. 2021 Employee Stock Purchase Plan, as amended (the "ESPP"), pursuant to the "evergreen" provisions of the ESPP, which provides for an automatic increase in the number of shares reserved and available for issuance under the ESPP on each January 1st until the ESPP terminates pursuant to its terms.

Pursuant to General Instruction E of Form S-8 regarding Registration of Additional Securities, the contents of the Registration Statement on Form S-8 filed with the Commission on August 23, 2021 (File No. 333-259000) are hereby incorporated by reference in this Registration Statement to the extent not replaced hereby.

------

**PART II** 

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT** 

**Item 8.** **<u>Exhibits</u>.** <br>

**EXHIBIT INDEX** 

---

| | |
|:---|:---|
| **Exhibit<br>No.** | **Description** |
| 4.1 | [Certificate of Incorporation of Cano Health, Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed on June 9, 2021).](http://www.sec.gov/Archives/edgar/data/1800682/000119312521186694/d191411dex31.htm) |
| 4.2 | [By-laws of Cano Health, Inc. (incorporated by reference to Exhibit 3.2 to the Current Report on Form 8-K filed on June 9, 2021).](http://www.sec.gov/Archives/edgar/data/1800682/000119312521186694/d191411dex32.htm) |
| 5.1\* | [Opinion of Goodwin Procter LLP.](d472960dex51.htm) |
| 23.1\* | [Consent of Ernst & Young LLP.](d472960dex231.htm) |
| 23.2\* | [Consent of Goodwin Procter LLP (included as part of Exhibit 5.1).](d472960dex51.htm) |
| 24.1\* | [Power of Attorney (included on signature page of the Registration Statement)](#sig). |
| 99.1 | [Cano Health, Inc. 2021 Employee Stock Purchase Plan (incorporated by reference to Annex K to the Proxy Statement/Prospectus filed on May 7, 2021).](http://www.sec.gov/Archives/edgar/data/1800682/000119312521155080/d107336d424b3.htm#annexk) |
| 99.2 | [First Amendment to Cano Health, Inc. 2021 Employee Stock Purchase Plan (incorporated by reference to Exhibit 99.3 to the Registration Statement on Form S-8 filed on August 23, 2021).](http://www.sec.gov/Archives/edgar/data/1800682/000119312521253536/d216664dex993.htm) |
| 99.3 | [Second Amendment to Cano Health, Inc. 2021 Employee Stock Purchase Plan dated December 14, 2021 (incorporated by reference to Exhibit 10.13 to the Annual Report on Form 10-K filed on March 14, 2022).](http://www.sec.gov/Archives/edgar/data/1800682/000180068222000010/a1013-esppsecondamendment.htm) |
| 107\* | [Filing Fee Table.](d472960dexfilingfees.htm) |

---

\* Filed herewith.

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Miami, State of Florida, on March 15, 2023.

---

| | |
|:---|:---|
| **CANO HEALTH, INC.** | **CANO HEALTH, INC.** |
| By: | /s/ Dr. Marlow Hernandez |
| Name: | Dr. Marlow Hernandez |
| Title: | Chief Executive Officer |

---

**POWER OF ATTORNEY** 

Each person whose signature appears below constitutes and appoints each of Marlow Hernandez and Brian D. Koppy, acting alone or together with another attorney-in-fact, as their true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for such person and in their name, place and stead, in any and all capacities, to sign any or all further amendments (including post-effective amendments) to this registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in their capacities and on the date indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Dr. Marlow Hernandez<br> Dr. Marlow Hernandez | Chief Executive Officer (Principal Executive Officer) | March 15, 2023 |
| /s/ Brian D. Koppy<br> Brian D. Koppy | Chief Financial Officer<br> (Principal Financial Officer) | March 15, 2023 |
| /s/ Mark Novell<br> Mark Novell | Chief Accounting Officer<br> (Principal Accounting Officer) | March 15, 2023 |
| /s/ Elliot Cooperstone<br> Elliot Cooperstone | Director | March 15, 2023 |
| /s/ Dr. Lewis Gold<br> Dr. Lewis Gold | Director | March 15, 2023 |
| /s/ Jacqueline Guichelaar<br> Jacqueline Guichelaar | Director | March 15, 2023 |
| /s/ Angel Morales<br> Angel Morales | Director | March 15, 2023 |
| /s/ Dr. Alan Muney<br> Dr. Alan Muney | Director | March 15, 2023 |
| /s/ Kim M. Rivera<br> Kim M. Rivera | Director | March 15, 2023 |
| /s/ Solomon Trujillo<br> Solomon Trujillo | Director | March 15, 2023 |

---

## Exhibit 5.1

Exhibit 5.1

---

| | |
|:---|:---|
| ![LOGO](g472960g0308052808431.jpg)  | Goodwin Procter LLP |
| ![LOGO](g472960g0308052808431.jpg)  | The New York Times Building |
| ![LOGO](g472960g0308052808431.jpg)  | 620 Eighth Avenue |
| ![LOGO](g472960g0308052808431.jpg)  | New York, NY 10018<br>|
| ![LOGO](g472960g0308052808431.jpg)  | goodwinlaw.com |
|  | +1 212 813 8800 |

---

March 15, 2023

Cano Health, Inc.

9725 NW 117th Avenue

Miami, FL 33178

Re: <u>Securities Being Registered under Registration Statement on Form S-8</u>

Ladies and Gentlemen:

We have acted as counsel to you in connection with your filing of a Registration Statement on Form S-8 (the "Registration Statement") pursuant to the Securities Act of 1933, as amended (the "Securities Act"), on or about the date hereof relating to an aggregate of 2,259,178 shares (the "Shares") of Class A common stock, $0.0001 par value per share ("Common Stock"), of Cano Health, Inc., a Delaware corporation (the "Company"), that may be issued pursuant to the Company's 2021 Employee Stock Purchase Plan, as amended (the "Plan").

We have reviewed such documents and made such examination of law as we have deemed appropriate to give the opinions set forth below. We have relied, without independent verification, on certificates of public officials and, as to matters of fact material to the opinion set forth below, on certificates of officers of the Company.

The opinion set forth below is limited to the Delaware General Corporation Law.

For purposes of the opinion set forth below, we have assumed that no event occurs that causes the number of authorized shares of Common Stock available for issuance by the Company to be less than the number of then unissued Shares.

Based on the foregoing, we are of the opinion that the Shares have been duly authorized and, upon issuance and delivery against payment therefor in accordance with the terms of the Plan, will be validly issued, fully paid and nonassessable.

This opinion letter and the opinion it contains shall be interpreted in accordance with the Core Opinion Principles as published in 74 Business Lawyer 815 (Summer 2019).

We hereby consent to the inclusion of this opinion as Exhibit 5.1 to the Registration Statement. In giving our consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.

Very truly yours,

/s/ GOODWIN PROCTER LLP

GOODWIN PROCTER LLP

## Exhibit 23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the Cano Health, Inc. 2021 Employee Stock Purchase Plan of our reports dated March 15, 2023, with respect to the consolidated financial statements of Cano Health, Inc. and the effectiveness of internal control over financial reporting of Cano Health, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2022, filed with the Securities and Exchange Commission.

/s/ Ernst & Young LLP

Miami, Florida

March 15, 2023

## Ex-Filing

EXHIBIT 107

**Calculation of Filing Fee Table** 

**Form S-8** 

(Form Type)

**Cano Health, Inc.** 

(Exact Name of Registrant as Specified in its Charter)

<u>Table 1—Newly Registered Securities</u> 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;Security Type | Security<br>Class<br> Title | Fee<br>Calculation<br>Rule | Amount<br>Registered(1) | Proposed<br>Maximum<br>Offering<br>Price Per<br>Share | Maximum<br>Aggregate Offering<br>Price | Fee<br> Rate | Amount of<br>Registration<br>Fee |
| &nbsp;&nbsp;&nbsp;Equity | Class A Common stock, $0.0001 par value per share | Rule 457(c) and Rule 457(h) | 2259178(2) | $1.05(3) | $2372136.90 | $0.00011020 | $261.41 |
| &nbsp;&nbsp;&nbsp;Total Offering Amounts | &nbsp;&nbsp;&nbsp;Total Offering Amounts | &nbsp;&nbsp;&nbsp;Total Offering Amounts | &nbsp;&nbsp;&nbsp;Total Offering Amounts |  |  |  | $261.41 |
| &nbsp;&nbsp;&nbsp;Total Fee Offsets | &nbsp;&nbsp;&nbsp;Total Fee Offsets | &nbsp;&nbsp;&nbsp;Total Fee Offsets | &nbsp;&nbsp;&nbsp;Total Fee Offsets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Net Fee Due | &nbsp;&nbsp;&nbsp;Net Fee Due | &nbsp;&nbsp;&nbsp;Net Fee Due | &nbsp;&nbsp;&nbsp;Net Fee Due |  |  |  | $261.41 |

---

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the " <u>Securities Act</u> "),
this registration statement shall also cover any additional shares of Cano Health, Inc.'s (the " <u>Registrant</u> ") Class A common stock, par value $0.0001 per share (the " <u>Common Stock</u> "), which become issuable
under the Registrant's 2021 Employee Stock Purchase Plan, as amended (the " <u>ESPP</u> "), by reason of any stock dividend, stock split, recapitalization or any other similar transaction effected without the receipt of consideration
which results in an increase in the number of our outstanding shares of Common Stock.

(2) Represents an automatic increase to the number of shares available for issuance under the ESPP in accordance
with the automatic annual increase provision of the ESPP. Accordingly, on January 1, 2023, the number of shares of Common Stock reserved and available for issuance under the ESPP increased by 2,259,178, which represents one percent (1%) of the
number of shares of Common Stock issued and outstanding on December 31, 2022. Shares available for issuance under the ESPP were previously registered on Form S-8 filed with the Securities and Exchange
Commission on August 23, 2021 (File No. 333-259000).

(3) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and (h) of
the Securities Act, and based on 85% of $1.23, the average of the high and low sales prices of the Common Stock, as quoted on the New York Stock Exchange, on March 14, 2023, which is a date within five business days prior to the filing of this
registration statement. Pursuant to the ESPP, the purchase price of the shares of Common Stock reserved for issuance thereunder will be 85% of the fair market value of a share of Common Stock on the first trading day of the applicable offering
period or on the exercise date of the applicable offering period, whichever is less.